BioSpace News Archive

Implantable device is implanted into heart tissue that detects unusual heart rhythm and delivers shock to retrieve the normal heart beat.

A chemical peel is a kind of skin treatment performed to aesthetically improve the structure of a tissue by the topical application of some acidic solution.

Bandage contact lenses are soft contact lenses that serve the purpose of protection of cornea from friction and irritation caused by mechanical rubbing of eyelids, and other functions including pain relief, healing, sealing, and maintenance of corneal hydration, thereby allowing the cornea to heal in conditions such as an eye injury or corneal diseases.

Dynacure announced that the US Food and Drug Administration has accepted its Investigational New Drug application for DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein, for the treatment of Myotubular and Centronuclear Myopathies.

Mispro Biotech Services, North America’s leading contract vivarium organization with locations in all major U.S. biotech hubs, including a facility in Kendall Square, has announced the addition of a second facility in Cambridge, set to open in Alewife this fall.

U.S. government commits to purchase approximately 1.7 million courses of Molnupiravir upon issuance of Emergency Use Authorization or approval by the U.S. Food and Drug Administration

Clearside Biomedical, Inc. announced that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer, will participate in two upcoming investor conferences in June 2021

Trillium Therapeutics Inc., a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced the voting results from its Annual General and Special Meeting of Shareholders held on June 8, 2021.

CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, congratulates Hannah Valantine, MD on her State of the Art Lecture at the 2021 American Transplant Congress about the importance of equity in transplantation and genomic solutions to improve inclusivity.

Multiple GM1 gangliosidosis program milestones expected in FY2021, including 12-month data updates from the ongoing dose-escalation study and meeting with FDA to align on registrational pathway